Charles Schwab Investment Management »

Prelude Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $276k 133k 2.07
2024-06-30 $488k 128k 3.81
2024-03-31 $604k 127k 4.74
2023-12-31 $533k 125k 4.27
2023-09-30 $380k 123k 3.09
2023-06-30 $386k 86k 4.50
2023-03-31 $358k 63k 5.70
2022-12-31 $385k 64k 6.04
2022-09-30 $358k 54k 6.62
2022-06-30 $330k 63k 5.22
2022-03-31 $524k 76k 6.90
2021-12-31 $1.1M 85k 12.45
2021-09-30 $2.6M 84k 31.26
2021-06-30 $2.1M 73k 28.64
2021-03-31 $3.2M 75k 43.34
2020-12-31 $4.9M 69k 71.56